Supported by an educational grant from Bayer
TITLE - Hemophilia: Clinical Considerations for Healthcare Professional
TARGET AUDIENCE - Target audiences for this program are Specialty Pharmacists, Pharmacists, Clinical Pharmacists, Specialty Pharmacy Executives, Pharmacy Directors, Chief Pharmacy Officers, Hemophilia Pharmacists, Hemophilia Nurses and Nurses
LEARNING OBJECTIVES - After completing the program, Specialty Pharmacists, Pharmacists, Clinical Pharmacists, Specialty Pharmacy executives, Pharmacy Directors, Chief Pharmacy Officers, Hemophilia Pharmacists, Hemophilia Nurses and Nurses, along with other healthcare practitioner participants will be able to:
- List and define the various types of hemophilia
- Review the characteristics of the most prevalent forms of hemophilia
- Discuss the pathophysiology of hemophilia and specific deficiencies in the coagulation process
- Recognize the signs, symptoms and complications of hemophilia
- Review the methods of diagnosis, including laboratory tests and clinical evaluation
- Identify the correct classification of disease severity
Before the activity, all faculty and anyone who is in a position to have control over the content of this activity and their spouse/life partner will disclose the existence of any financial interest and/or relationship(s) they might have with any commercial interest producing healthcare goods/ services to be discussed during their presentation(s): honoraria, expenses, grants, consulting roles, speakers bureau membership, stock ownership, or other special relationships. Presenters will inform participants of any off-label discussions. All identified conflicts of interest are thoroughly vetted by the Specialty Pharma Education Center for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations.
Pharmacist continuing education credit
Specialty Pharma Education Center (SPEC) is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmaceutical education. This program is approved for 1.5 hours (0.15CEUs) of continuing pharmacy education credit. Proof of participation will be posted to your NABP CPE profile within 4 to 6 weeks to participants who have successfully completed the post-test. Participants must participate in the entire presentation and complete the course evaluation to receive continuing pharmacy education credit.
Knowledge Based Activity
Course release date 6/21/2017
Course expires 6/21/2020
Nursing continuing education credit
Educational Review Systems is an approved approver of continuing nursing education by the Alabama State Nursing Association, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation. Provider # 5-115. This program is approved for 1.5 hours of continuing nursing education.
Educational Review Systems is also approved for nursing continuing education by the state of California, the state of Florida and the District of Columbia.
Course release date 7/24/2017
Course expires 7/24/2019
|Activity Number||Credit Amount||Accreditation Period|
|0535-0000-17-020-H01-P||0.15 CEUs||June 21, 2017 - June 21, 2020|
|0535-0000-17-020-H01-N||1.5 hours of CNE||July 24, 2017 - July 24, 2019|